IP Verse

Control System For Control Of Distribution Of Medication - EP3201808

The patent EP3201808 was granted to Zogenix on Oct 20, 2021. The application was originally filed on Sep 28, 2015 under application number EP15813093A. The patent is currently recorded with a legal status of "Revoked".

EP3201808

ZOGENIX
Application Number
EP15813093A
Filing Date
Sep 28, 2015
Status
Revoked
Aug 30, 2024
Grant Date
Oct 20, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELKINGTON AND FIFEJul 13, 2022ELKINGTON AND FIFEADMISSIBLE

Patent Citations (37) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS6045501
DESCRIPTIONUS6315720
DESCRIPTIONUS6561976
DESCRIPTIONUS6561977
DESCRIPTIONUS6755784
DESCRIPTIONUS6869399
DESCRIPTIONUS6908432
DESCRIPTIONUS7141018
DESCRIPTIONUS7668730
DESCRIPTIONUS7765106
DESCRIPTIONUS7765107
DESCRIPTIONUS779717
DESCRIPTIONUS7874984
DESCRIPTIONUS7895059
DESCRIPTIONUS7959566
DESCRIPTIONUS8204763
DESCRIPTIONUS8263650
DESCRIPTIONUS8315886
DESCRIPTIONUS8457988
DESCRIPTIONUS8589182
DESCRIPTIONUS8589188
DESCRIPTIONUS8626531
DESCRIPTIONUS8731963
DESCRIPTIONWO2014177676
EXAMINATIONUS2008004904
INTERNATIONAL-SEARCH-REPORTEP2399513
INTERNATIONAL-SEARCH-REPORTUS2002038310
INTERNATIONAL-SEARCH-REPORTUS8386274
INTERNATIONAL-SEARCH-REPORTWO2010104841
OPPOSITIONEP2399513
OPPOSITIONUS2005260610
OPPOSITIONUS2008004904
OPPOSITIONUS2014329908
OPPOSITIONUS8386274
OPPOSITIONWO2007034476
OPPOSITIONWO2007079181
OPPOSITIONWO2010104841

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- Junri Hattori ET AL, "A Screening test for the prediction of Dravet syndrome before one year of age", EPILEPSIA, NEW YORK, US, (20080401), vol. 49, no. 4, doi:10.1111/j.1528-1167.2007.01475.x, ISSN 0013-9580, pages 626 - 633, XP055596080
EXAMINATION- Berten Ceulemans ET AL, "Successful use of fenfluramine as an add-on treatment for Dravet syndrome", Epilepsia, (20120503), vol. 53, no. 7, doi:10.1111/j.1528-1167.2012.03495.x, ISSN 0013-9580, pages 1131 - 1139, XP055123152
OPPOSITION- BNF 39 - BRITISH NATIONAL FORMULARY, (20000300), page 197, XP055946463-
OPPOSITION- MIMS - monthly index of medical specialities, (19970901), pages 240 - 241, XP055946455-
OPPOSITION- HATTORI et al., "A screening test for the prediction of Dravet syndrome before one year of age", Epilepsia, (20080000), vol. 49, no. 4, doi:10.1111/j.1528-1167.2007.01475.x, pages 626 - 633, XP055596080
OPPOSITION- CEULEMANS et al., "Successful use of fenfluramine as an add-on treatment for Dravet syndrome", Epilepsia, (20120000), vol. 53, no. 7, doi:10.1111/j.1528-1167.2012.03495.x, pages 1131 - 1139, XP055123152

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents